Arrowhead Pharma (ARWR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Sales | 7,632 | 27,376 | 23,529 | 29,455 | 43,293 |
| Gross Profit | 7,632 | 27,376 | 23,529 | 29,455 | 43,293 |
| Operating Expenses | 57,752 | 43,322 | 45,769 | 34,308 | 33,655 |
| Operating Income | -50,120 | -15,946 | -22,240 | -4,853 | 9,638 |
| Other Income | 1,689 | 2,335 | 2,404 | 2,180 | 2,241 |
| Pre-tax Income | -48,431 | -13,611 | -19,836 | -2,673 | 11,879 |
| Net Income Continuous | -48,433 | -13,611 | -19,836 | -2,673 | 11,705 |
| Net Income | $-48,433 | $-13,611 | $-19,836 | $-2,673 | $11,705 |
| EPS Basic Total Ops | -0.48 | -0.13 | -0.20 | -0.03 | 0.13 |
| EPS Basic Continuous Ops | -0.48 | -0.13 | -0.20 | -0.03 | 0.12 |
| EPS Diluted Total Ops | -0.48 | -0.13 | -0.20 | -0.03 | 0.11 |
| EPS Diluted Continuous Ops | -0.48 | -0.13 | -0.20 | -0.03 | 0.11 |
| EBITDA(a) | $-48,474 | $-14,176 | $-20,626 | $-3,416 | $11,107 |